|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.60 CNY | +1.05% |
|
+4.74% | +11.93% |
| 23/04 | Fujian Funeng's Profit Rises 6% in 2025 | MT |
| 23/04 | Fujian Funeng's Attributable Profit Slides 12% in Q1 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.71 | 4.06 | 3.81 | 4.03 | 3.83 | |||||
Return on Total Capital | 2.99 | 4.42 | 4.11 | 4.24 | 4.01 | |||||
Return On Equity % | 7.59 | 14.2 | 12.18 | 11.64 | 11 | |||||
Return on Common Equity | 7.64 | 13.73 | 12.52 | 11.84 | 11.22 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 17.1 | 23.91 | 23.81 | 26.51 | 28.67 | |||||
SG&A Margin | 2.23 | 1.94 | 2.15 | 2.48 | 2.77 | |||||
EBITDA Margin % | 24.67 | 32.11 | 33.37 | 35.15 | 37.44 | |||||
EBITA Margin % | 14.26 | 21.09 | 20.68 | 22.85 | 24.9 | |||||
EBIT Margin % | 14.14 | 21 | 20.58 | 22.71 | 24.77 | |||||
Income From Continuing Operations Margin % | 12.63 | 22.93 | 21.76 | 23.91 | 26.53 | |||||
Net Income Margin % | 10.5 | 18.11 | 17.85 | 19.18 | 21.51 | |||||
Net Avail. For Common Margin % | 10.5 | 18.11 | 17.85 | 19.18 | 21.51 | |||||
Normalized Net Income Margin | 6.73 | 11.31 | 11.54 | 12.53 | 15.02 | |||||
Levered Free Cash Flow Margin | -47.77 | 4.15 | -1.68 | -6.1 | 3.08 | |||||
Unlevered Free Cash Flow Margin | -44.95 | 7.06 | 1.1 | -3.72 | 4.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.31 | 0.31 | 0.3 | 0.28 | 0.25 | |||||
Fixed Assets Turnover | 0.54 | 0.52 | 0.53 | 0.54 | 0.49 | |||||
Receivables Turnover (Average Receivables) | 4.01 | 3.67 | 3.06 | 2.76 | 2.49 | |||||
Inventory Turnover (Average Inventory) | 20.56 | 17.8 | 16.47 | 17.16 | 16.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.16 | 1.14 | 1.55 | 2.55 | 3.12 | |||||
Quick Ratio | 0.98 | 1 | 1.42 | 2.38 | 2.97 | |||||
Operating Cash Flow to Current Liabilities | 0.38 | 0.38 | 0.61 | 0.99 | 0.92 | |||||
Days Sales Outstanding (Average Receivables) | 91.08 | 99.58 | 119.14 | 132.38 | 146.66 | |||||
Days Outstanding Inventory (Average Inventory) | 17.76 | 20.51 | 22.16 | 21.33 | 22.06 | |||||
Average Days Payable Outstanding | 18.09 | 19.34 | 15.98 | 13.18 | 13.71 | |||||
Cash Conversion Cycle (Average Days) | 90.75 | 100.75 | 125.32 | 140.54 | 155.01 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 88.53 | 80.51 | 71 | 55.47 | 64.66 | |||||
Total Debt / Total Capital | 46.96 | 44.6 | 41.52 | 35.68 | 39.27 | |||||
LT Debt/Equity | 74.76 | 62.34 | 53.51 | 46.9 | 54.82 | |||||
Long-Term Debt / Total Capital | 39.65 | 34.54 | 31.29 | 30.17 | 33.29 | |||||
Total Liabilities / Total Assets | 50.97 | 49.46 | 44.86 | 38.5 | 41.82 | |||||
EBIT / Interest Expense | 3.14 | 4.51 | 4.64 | 5.97 | 8.18 | |||||
EBITDA / Interest Expense | 5.52 | 6.9 | 7.53 | 9.24 | 12.37 | |||||
(EBITDA - Capex) / Interest Expense | -6.33 | 4.16 | 4.34 | 3.39 | 3.9 | |||||
Total Debt / EBITDA | 6.36 | 4.29 | 4.04 | 3.45 | 4.32 | |||||
Net Debt / EBITDA | 5.39 | 3.43 | 2.85 | 2.35 | 2.18 | |||||
Total Debt / (EBITDA - Capex) | -5.54 | 7.12 | 7 | 9.42 | 13.72 | |||||
Net Debt / (EBITDA - Capex) | -4.69 | 5.69 | 4.95 | 6.41 | 6.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 26.37 | 17.79 | 2.63 | -0.9 | -5.58 | |||||
Gross Profit, 1 Yr. Growth % | -8.97 | 59.89 | 2.21 | 10.34 | 2.13 | |||||
EBITDA, 1 Yr. Growth % | -3.97 | 50.3 | 6.58 | 4.27 | 0.48 | |||||
EBITA, 1 Yr. Growth % | -14.4 | 67.6 | 0.49 | 9.3 | 2.77 | |||||
EBIT, 1 Yr. Growth % | -13.58 | 68.58 | 0.63 | 9.32 | 3.01 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -4.4 | 98.57 | -2.65 | 8.93 | 4.78 | |||||
Net Income, 1 Yr. Growth % | -15.18 | 90.79 | 1.11 | 6.47 | 5.87 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -26.84 | 93.74 | 1.04 | 3.09 | 4 | |||||
Normalized Net Income, 1 Yr. Growth % | -30.47 | 89.32 | 4.76 | 7.71 | 12.98 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 48.18 | 4.34 | -2.33 | -0.33 | 5.66 | |||||
Inventory, 1 Yr. Growth % | 18.83 | 31.49 | -4.5 | -12.18 | 3.25 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.58 | 49.4 | 4.98 | 14.72 | -3.66 | |||||
Total Assets, 1 Yr. Growth % | 26.35 | 9.97 | 4.45 | 2.34 | 14.11 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.15 | 13.3 | 9.24 | 14.81 | 8.84 | |||||
Cash From Operations, 1 Yr. Growth % | 2.25 | 37.54 | 41.14 | 1.29 | 9.05 | |||||
Capital Expenditures, 1 Yr. Growth % | 34.93 | -71.61 | 13.37 | 56.24 | 8.8 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 316.73 | -110.38 | -141.46 | 260.51 | -148.46 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 401.41 | -118.78 | -84.02 | -435.28 | -229.63 | |||||
Dividend Per Share, 1 Yr. Growth % | -22.24 | 90.53 | 0.75 | 0 | 37.42 | |||||
Common Equity, 1 Yr. Growth % | 14.11 | 12.31 | 9.69 | 15.3 | 8.46 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.2 | 22.4 | 9.95 | 0.85 | -3.27 | |||||
Gross Profit, 2 Yr. CAGR % | -0.01 | 22.82 | 27.84 | 6.2 | 6.16 | |||||
EBITDA, 2 Yr. CAGR % | 3.31 | 21.73 | 26.63 | 5.47 | 2.4 | |||||
EBITA, 2 Yr. CAGR % | -1.53 | 22.51 | 29.87 | 4.9 | 6.05 | |||||
EBIT, 2 Yr. CAGR % | -1.57 | 23.33 | 30.25 | 4.89 | 6.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 7.51 | 43.43 | 39.06 | 2.98 | 6.83 | |||||
Net Income, 2 Yr. CAGR % | 0.98 | 31.69 | 38.93 | 3.76 | 6.17 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -8.71 | 22.97 | 40.37 | 2.06 | 3.55 | |||||
Normalized Net Income, 2 Yr. CAGR % | -5.77 | 17.73 | 40.81 | 6.15 | 10.41 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 28.01 | 24.52 | 0.95 | -1.34 | 2.62 | |||||
Inventory, 2 Yr. CAGR % | 12.97 | 25 | 12.06 | -8.42 | -4.78 | |||||
Accounts Receivable, 2 Yr. CAGR % | 29.51 | 27.37 | 25.24 | 9.75 | 5.13 | |||||
Total Assets, 2 Yr. CAGR % | 25.49 | 18.06 | 7.18 | 3.39 | 8.06 | |||||
Common Equity, 2 Yr. CAGR % | 18.2 | 13.53 | 11 | 12.46 | 11.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | 19.79 | 14.57 | 11.26 | 11.99 | 11.79 | |||||
Cash From Operations, 2 Yr. CAGR % | -7.62 | 20.37 | 39.33 | 19.57 | 5.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | 63.47 | -38.11 | -43.26 | 33.09 | 30.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 174.12 | -34.5 | -79.25 | 22.26 | 31.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 245.26 | -3.38 | -82.68 | -26.81 | 105.74 | |||||
Dividend Per Share, 2 Yr. CAGR % | -8.36 | 21.72 | 38.55 | 0.37 | 17.23 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.89 | 12.92 | 15.42 | 6.21 | -1.34 | |||||
Gross Profit, 3 Yr. CAGR % | 4.13 | 18.33 | 15.53 | 21.72 | 4.83 | |||||
EBITDA, 3 Yr. CAGR % | 5.75 | 18.1 | 16.49 | 18.73 | 3.81 | |||||
EBITA, 3 Yr. CAGR % | 3.17 | 19.35 | 14.73 | 22.69 | 4.23 | |||||
EBIT, 3 Yr. CAGR % | 3.17 | 19.47 | 15.24 | 22.86 | 4.26 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 12.12 | 35.5 | 26.07 | 28.19 | 3.57 | |||||
Net Income, 3 Yr. CAGR % | 6.49 | 27.75 | 20.61 | 27.14 | 4.46 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -4.09 | 19.87 | 15.42 | 26.65 | 2.7 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.38 | 20.96 | 13.23 | 28.72 | 8.44 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 20.06 | 19.69 | 14.83 | 0.52 | 0.94 | |||||
Inventory, 3 Yr. CAGR % | -0.7 | 18.84 | 14.27 | 3.31 | -4.69 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.8 | 35.83 | 19.42 | 21.63 | 5.08 | |||||
Total Assets, 3 Yr. CAGR % | 17.37 | 20.21 | 13.34 | 5.54 | 6.84 | |||||
Common Equity, 3 Yr. CAGR % | 14.63 | 16.43 | 12.24 | 12.42 | 11.11 | |||||
Tangible Book Value, 3 Yr. CAGR % | 16.12 | 17.82 | 12.77 | 12.43 | 10.93 | |||||
Cash From Operations, 3 Yr. CAGR % | 2.61 | 6.54 | 26.93 | 25.28 | 15.95 | |||||
Capital Expenditures, 3 Yr. CAGR % | 62.4 | -8.79 | -24.27 | -20.48 | 24.44 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 187.41 | -8.2 | -43.76 | -46.26 | -10.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 119.17 | 30.44 | -46.97 | -53.49 | -12.22 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 16.96 | 14.28 | 24.28 | 11.45 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.68 | 16.06 | 9.45 | 7.93 | 7.55 | |||||
Gross Profit, 5 Yr. CAGR % | 2.95 | 19.64 | 13.84 | 13.32 | 11.69 | |||||
EBITDA, 5 Yr. CAGR % | 5.64 | 18.78 | 14.25 | 12.9 | 10.66 | |||||
EBITA, 5 Yr. CAGR % | 1.73 | 20.15 | 14.14 | 13.37 | 11.22 | |||||
EBIT, 5 Yr. CAGR % | 1.67 | 20.28 | 14.23 | 13.41 | 11.5 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 7.35 | 31.05 | 24.19 | 21.42 | 17.99 | |||||
Net Income, 5 Yr. CAGR % | 4.56 | 25.18 | 20.09 | 17.56 | 14.61 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.89 | 18.09 | 13.15 | 12.55 | 10.52 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.24 | 20.32 | 15.59 | 14.8 | 12.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.21 | 19.45 | 12.07 | 10.79 | 9.78 | |||||
Inventory, 5 Yr. CAGR % | 10 | 13.79 | 4.22 | 7.07 | 6.23 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.54 | 26.99 | 21.33 | 24.72 | 13.49 | |||||
Total Assets, 5 Yr. CAGR % | 19.63 | 19.68 | 13.25 | 13.18 | 11.2 | |||||
Common Equity, 5 Yr. CAGR % | 12.12 | 13.71 | 13.29 | 14.83 | 12.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.1 | 14.97 | 14.29 | 15.46 | 12.38 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.59 | 14.03 | 16.66 | 11.57 | 17.7 | |||||
Capital Expenditures, 5 Yr. CAGR % | 38.07 | 7.71 | 6.63 | 6.09 | -5.89 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 86.98 | 78.4 | 0.27 | 2.95 | -21.1 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 132.05 | 37.33 | -20.72 | 3.52 | -8.79 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0.98 | 14.88 | 13.93 | 10.02 | 15.45 |
- Stock Market
- Equities
- 600483 Stock
- Financials Fujian Funeng Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















